PRO-1107 by ProfoundBio Suzhou for Endometrial Cancer: Likelihood of Approval

PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Phase II for Endometrial Cancer.

Apr 21, 2024 - 00:00
PRO-1107 is under clinical development by ProfoundBio Suzhou and currently in Phase II for Endometrial Cancer.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow